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HIV testing is a critical entry point to life-saving 
antiretroviral therapy (ART) for those diagnosed with 
HIV and to prevention services for those at high-
risk of acquiring HIV. Despite advances in testing, 
there remain a variety of social and programmatic 
challenges that prevent access to HIV testing services 
(HTS), particularly for men and key populations. HIV 
program managers and policymakers are increasingly 
invested in understanding how best to deliver HTS to 
different populations and maximize health system 
resources at facility and community levels.
Project SOAR recognizes the key role that HTS plays 
in achieving UNAIDS’ 90-90-90 goals for controlling 
the HIV epidemic through testing, treatment, and 
viral suppression by 2020. Drawing on its extensive 
portfolio, Project SOAR has contributed to the 
evidence base and catalyzed research use by 
examining HIV testing among key populations, which 
also can inform strategies to help other populations 
to initiate and remain in care, reach viral suppression, 
and achieve positive health outcomes. 
This brief synthesizes results from 12 studies across 
10 countries (see map on next page for additional 
detail) that examined:
 z Barriers to and enablers of HIV testing uptake
 z Strategies for increasing uptake, optimizing 
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Expand context-specific testing strategies at 
multiple levels of the health system. Based on 
SOAR research to date, these include:  
1. HIV self-testing options to promote agency, 
awareness, and self-care, especially among 
key populations.
2. Integrated, community-based interventions, 
including DREAMS, to increase testing 
among adolescent girls and young women 
and their partners.
3. Enhanced facility-based services that 
leverage participatory approaches to 
identify and address HIV testing bottlenecks 
and gaps facing adult clients. Prioritize 
re-testing of HIV-negative pregnant and 
postpartum women to reach infants.
4. Rigorous quality management in HIV 
laboratory testing to avoid misclassification 
of results and unnecessary delays in care. 
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ABOUT
Project SOAR (Supporting Operational AIDS Research), 
was a 6-year USAID-funded implementation science 
initiative with over 70 activities in 21 countries. The 
Population Council led Project SOAR in collaboration with 
Avenir Health, Elizabeth Glaser Pediatric AIDS Foundation 
(EGPAF), Johns Hopkins University, Palladium, and The 
University of North Carolina at Chapel Hill.
Research Utilization
Project SOAR implemented a systematic and proactive 
research utilization (RU) approach to advance translation 
of research results into evidence-informed practice. This 
RU approach supported inclusion of end data users in 
the research process from inception to dissemination 
and fostered data-driven policy and program change.
Series
“Learnings from Project SOAR” seeks to highlight key 
results, recommendations, and examples of research 
impact across this 6-year, 21-country initiative. 
The series includes five thematic briefs focused on 
biomedical prevention interventions, HIV testing services, 
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BARRIERS TO AND ENABLERS OF 
HIV TESTING UPTAKE
Key findings
In South Africa, interviews with patients, 
clinicians, and counselors revealed a variety 
of staff and client challenges to facility-based 
HIV testing. 
To gain a richer understanding of the barriers to and 
opportunities for HTS from different perspectives, 
SOAR researchers conducted 22 in-depth interviews 
with clinic patients, clinicians, and HTS counselors. 
Despite spending more time with patients and having 
a greater role within HTS than a nurse or a doctor, HTS 
counselors often felt undervalued and unmotivated, 
and struggled with poorly defined roles, limited 
renumeration and acknowledgement, and lack of 
adequate workspaces. Clinicians mentioned huge 
workloads and clients’ refusal to accept HTS. It was 
also noted that in only selecting suspected HIV cases 
and waiting until the end of consultations to offer 
HTS, they routinely missed multiple opportunities 
for testing. Clinic patients noted lack of privacy and 
confidentiality, fear of knowing one’s HIV status, 
and long queues and additional waiting times of 
nearly one hour as barriers to testing.1
In Malawi and Kenya, male partners of ado-
lescent girls and young women (AGYW) also 
identified multiple barriers to testing but 
were motivated to seek care due to trust in 
providers, quality of services, and flexible 
hours. 
In Malawi, SOAR researchers conducted focus group 
discussions with 157 male partners of AGYW and in-
depth interviews with 49 men living with HIV to learn 
how to better engage men in HIV services. Similarly, 
in Kenya, researchers interviewed men who had 
sought HIV testing and men living with HIV to learn 
more about their perceived barriers to HIV testing and 
linkage to care. Study participants in both countries 
identified stigma and fear of testing positive as 
barriers to HIV testing, and also reported low HIV risk 
perception. Facility-related barriers included long 
wait times that disrupted livelihoods, lack of privacy 
and confidentiality, and distance to health services.2
Overview: To design effective programs and 
reduce disparities in uptake of HIV testing, 
country-specific data are needed regarding 
facilitators and barriers to HIV testing. SOAR 
examined factors influencing HIV testing in 
Cameroon, Kenya, Malawi, Senegal, South 
Africa, and Uganda and through surveys and 
interviews with providers and patients. 
Results Summary: There remain critical 
individual-level barriers to testing due 
to stigma and fear, as well as facility-
level barriers such as lack of privacy and 
confidentiality, distance, lack of integrated 
services, and missed provider opportunities for 
testing. Key enablers promoting testing among 
patients included trust in providers, quality of 
services, and flexible facility hours. Continued 
community- and country-level research efforts 
can help to support tailored and evidence-
based interventions.      
Figure 1  Testing disparities in South Africa, Malawi, 
                 and Kenya
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In the Kenya study, men accessing HTS identified 
several factors that motivated them to seek services. 
These included having high risk perception; being ill; 
awareness of partner’s status; having trust in the 
privacy, confidentiality, and quality of services; and 
flexible/extended operating hours.3
In Cameroon, Senegal, and Uganda,  findings 
from a pilot of the updated People Living with 
HIV (PLHIV) Stigma Index 2.0 indicated that 
stigma remains a critical barrier to testing. 
In 2017, Project SOAR researchers updated and 
tested the draft Stigma Index 2.0 (in collaboration with 
the original developers) in three countries: Cameroon, 
Senegal, and Uganda. Respondents were recruited 
from PLHIV networks, community-based organizations 
serving key populations, ART clinics, and through 
snowball sampling. A total of 1,207 PLHIV (about 400 
in each country) participated in the pilot study. The 
majority of participants were in their mid-30s, female, 
and had known their HIV status for more than six 
years. Survey data reveal that delaying getting tested 
for HIV because of fears about how other people 
would respond if they tested positive ranged from 
23 percent in Cameroon to a high of 41 percent in 
Uganda, indicating that stigma remains an important 
barrier to testing.4
In Nigeria, SOAR found suboptimal uptake of 
clinic-based testing among key populations, 
though testing was more common among 
men who have sex with men (MSM) and 
female sex workers (FSWs) recruited through 
outreach.
Researchers in Nigeria enrolled 605 untreated 
HIV-positive participants comprising 342 FSWs and 
263 MSM in a cohort study in 2017/2018. While 
national guidance recommends that key populations 
be tested every three months, more than a fourth of 
FSWs and MSM had never been tested for HIV prior 
to enrollment. Recent HIV testing was more common 
among FSWs and MSM recruited through outreach 
than through the clinic, suggesting the important role 
outreach can play in meeting the country’s testing 
guidelines. 
STRATEGIES FOR INCREASING 
UPTAKE, OPTIMIZING DELIVERY, 
AND IMPROVING QUALITY OF HTS  
Overview: While there exist a variety of 
avenues for HIV testing and initiation of care, 
these often remain underutilized by many 
potentially vulnerable communities, including 
infants, orphans and vulnerable children (OVC), 
AGYW, men, MSM, and FSWs. SOAR examined 
strategies for improving quality HTS delivery 
to these populations at different levels of care 
in Kenya, Lesotho, Malawi, Nigeria, Rwanda, 
Senegal, South Africa, Tanzania, and Uganda. 
Results Summary: 
Individual level—Self-testing is an acceptable 
approach to reach key populations that face 
barriers to engaging with routine outlets. 
Community-based—Integrated, community-
based approaches are an effective way to 
improve testing among AGYW and their 
partners. 
Facility-based services—Birth testing, screening 
tools for OVC, and enhanced ART delivery 
among pregnant and post-partum women can 
improve HIV testing and treatment initiation 
among infants and children. Systems-level 
approaches have the potential to increase 
rates of testing, including among men. 
Optimizing testing resources—Screening tools, 
standardization of testing guidelines, and 
rigorous quality assurance measures for lab 
testing can reduce misdiagnoses and delays in 
care. 
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Key findings: Individual-level 
In Senegal, HIV self-testing (HIVST) was effec-
tive in reaching undiagnosed key populations. 
In Senegal, SOAR used venue and social network 
approaches to distribute HIVST kits to key populations, 
including MSM and FSWs. A total of 1,839 HIVST 
kits were distributed in 2017/2018 and recipients 
participated in the pre- and post-test questionnaires. 
Use and acceptability of HIVST was high: 94 percent 
of post-test recipients used the kit, the vast majority 
within two days. Distribution of kits reached a high 
proportion of first-time testers, including about half of 
MSM who participated in the follow-up survey. About 3 
percent had a positive result, many of whom were first-
time testers, but only nine who tested positive went for 
confirmatory testing. In addition, none with an invalid 
test result went for follow-up testing. The results 
from this study demonstrate that HIVST provides a 
complementary approach to reach populations who 
may face barriers to engagement with existing and 
routine HTS, including first-time testers (Figure 2). 
The study also highlights the importance of leveraging 
existing networks for distribution of HIVST kits and 
the need for active follow-up to support confirmatory 
testing.5  
Key findings: Community-based
In Malawi, an integrated, community-based 
program for AGYW was associated with an 
increase in HIV testing and knowledge of part-
ner’s HIV status.
Project SOAR assessed the extent to which the 
DREAMS (Determined, Resilient, Empowered AIDS-
free, Mentored, and Safe) initiativea in Malawi 
contributed to reducing HIV risk among AGYW and 
their partners. A prospective cohort study was 
conducted with out-of-school AGYW (age 15–24 years) 
participating in DREAMS programming. Surveys and 
qualitative interviewers were conducted to assess 
the effects of multi-component, community-based 
interventions on a range of outcomes, including 
positive sexual health behaviors, improved knowledge 
and skills to increase self-efficacy, and economic 
empowerment. AGYW in the cohort reported 
significantly higher rates of HIV testing in the last 
12 months at endline. There was also a significant 
increase in knowledge of partner’s HIV status. Of 
AGYW who knew their partner’s HIV status at endline, 
89 percent learned about it via couples’ counseling 
and 83 percent of couples had been tested 
within the last year at a government health facility. 
Interviewed AGYW reported that they often tested 
with their partners, and all AGYW reported having a 
positive experience at the health facility.2
In South Africa, a community-based program 
focused on urban informal settlements led 
to an increase in testing among women but 
struggled to reach men.
SOAR researchers used a representative sample of 
1,528 adult men (18–35) and women (18–24) from 
a longitudinal study to evaluate the Asibonisane 
Community Responses program implemented in 
urban informal settlements in KwaZulu-Natal, South 
Africa. The program was designed to promote uptake 
of HIV services and transform gender norms to create 
aIn specific high HIV-risk communities, DREAMS delivered through the 
public and private sector, a comprehensive package of evidence-based, 
prevention strategies. These strategies went beyond the health sector 
to address the structural drivers that fuel AGYW’s HIV risk, including 
poverty, gender inequality, sexual violence, social isolation, and limited 
schooling.
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an enabling environment for HIV prevention behaviors 
among adult men and women. Although 90 percent 
had been tested for HIV at some point in the past at 
baseline, a lower proportion had been tested in the 
last six months. Program participation led to a 17 
percent increase in the probability of testing for 
women but had no effect on testing for men due, in 
part, to the fact that the program did not reach men 
who were least likely to be tested, such as men who 
had recently migrated to the community.6  
Key findings: Facility-based testing 
services 
Post-partum 
In Lesotho and Rwanda, testing at birth was found 
to be acceptable and offered benefits to infants. 
However, countries need to consider costs and im-
plementation feasibility before its adoption. 
In Lesotho and Rwanda, SOAR researchers evaluated 
the feasibility, acceptability, and cost of diagnosing 
HIV at birth, utilizing a multi-component mixed 
methods study. Birth testing was acceptable to 
women, health workers, and laboratory staff, with 
most recommending rolling out birth testing nationally. 
The major benefit cited by women and health workers 
was earlier knowledge of the child’s HIV status and 
therefore earlier initiation of treatment for positive 
children resulting in a reduction in infant mortality. 
Most women interviewed had no negative perceptions 
of very early infant diagnosis and generally expressed 
satisfaction with how services were delivered. While 
infants identified as infected at birth were initiated 
on treatment more quickly than those tested at six 
weeks, the turnaround time for receiving results was 
still long and varied between one and two months. 
In order to reduce turnaround time, it may be less 
burdensome and costly to strengthen counseling, 
tracing, and testing efforts beginning at six weeks of 
life rather than adding birth testing.7 
Pedatric
In Kenya and Uganda, undetected HIV infection and 
failure to distribute ART to pregnant and breastfeed-
ing women contributed to missed detection of HIV 
infection in children. 
In Kenya and Uganda, SOAR investigated missed 
pediatric cases to better understand where and 
why cases were not identified earlier. Researchers 
assessed a total of 174 newly identified, HIV-positive 
children, ages 2–14. Nearly 75 percent were 
diagnosed in outpatient departments and maternal 
and child health/prevention of mother-to-child 
transmission of HIV entry points. Undetected incident 
HIV infection and non-receipt of ART by mothers 
contributed to missed detection of infection in 
children. Two-thirds of the children’s mothers tested 
in antenatal care were HIV negative, suggesting 
becoming infected later in the pregnancy or post-
partum. Lack of re-testing of HIV-negative mothers 
during pregnancy and postpartum and failure to link 
newly diagnosed and known HIV-positive women 
to treatment are missed opportunities to identify 
pediatric cases.8
Figure 3  Pediatric case finding in Kenya and Uganda
Of 95 mothers who had an 
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Adult
In South Africa, a participatory, systems approach 
was found to increase uptake of facility-based HIV 
testing, successfully reaching men. 
Project SOAR tested a systems approach to streamline 
facility-based HTS in 10 public health facilities in 
Gauteng province, South Africa. Before use of a 
systems approach, HTS was typically offered to 
patients after two or more hours of waiting in multiple 
queues. Based on formative data to identify gaps 
and bottlenecks, the clinics implemented a number 
of system-level changes, including promoting HTS 
daily in waiting areas, increasing recommendations 
of HTS by clinicians, shifting the time during a visit 
when HTS was recommended, and adjusting HTS 
counselor hours to increase availability and private 
counseling space. Comparing data from before 
and after implementation of the system changes, a 
considerably higher proportion of patients reported 
being offered testing. Among those who received 
testing, the absolute number of people tested 
increased, and proportion of male testers increased 
from 20 to 38 percent. The study highlights the role 
a systems approach can play in enhancing facility-
based HTS. Despite the improvements, the offering 
and uptake of HIV testing remained low overall.1  
Key findings: Optimizing testing 
resources 
In Tanzania, a pediatric HIV risk assessment 
tool was feasible for screening children and 
adolescents in communities and facilities, 
but administration of screening questions 
was inconsistent in communities.
Screening tools that identify children most vulnerable 
to HIV can help prioritize testing resources for those 
individuals. SOAR tested HIV risk screening tools 
in Tanzania among nearly 20,000 children and 
adolescents in communities and facilities. The optimal 
screening tool had five items: whether a relative had 
died, ever admitted to hospital, have a family member 
with HIV, have a cough, or was the adolescent 
sexually active (if over age 10). This short screening 
tool—for which those who had at least one of these 
characteristics was classified as eligible for testing—
had a sensitivity of 85 percent, and specificity of 
44 percent, as compared to participants’ HIV test 
results. Community participants and community care 
workers who administered the screening tool found 
home-based HIV risk screening and testing to be 
acceptable, but fidelity to the screening questions 
was inconsistent, with community care workers often 
skipping questions. As HIV risk screening tools are 
scaled up in Tanzania and beyond, close monitoring 
of implementation is critical, as are cost-effectiveness 
analyses.9,10  
In Nigeria, standardization of testing guide-
lines and rigorous quality management of lab-
oratory tests resulted in no misclassification 
of rapid test results.
Misclassification of HIV status has been reported 
to occur due to false-positive diagnoses; in some 
settings, misclassifications have been substantial, 
carrying a heavy social and financial cost. SOAR 
assessed HIV-positive misclassification rates among 
newly diagnosed key and general population clients 
in a selection of programs in Nigeria where “test 
and treat” has been implemented. A total of 788 
confirmatory blood samples were collected from 
newly diagnosed HIV-positive clients. In this study, 
there was no misclassification of rapid test results, 
confirming that only HIV-positive clients were placed 
on treatment. The perfect concordance between 
rapid HIV test and ELISA from all the sites may be 
attributable to the oversight of a HTS technical 
working group and the adherence of implementing 
partners to the standardized and rigorous quality 
assurance management system for both community 
and facility-based HIV testing services.11
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RESEARCH IMPACT SPOTLIGHT
Senegal Test and Start (TnS) Study Informs Large-scale Distribution of HIVST Kits in Senegal
Project SOAR’s Senegal TnS study demonstrated that expanding access to HIVST may increase HIV testing 
among key populations and can effectively engage first-time testers. As a result, the Ministry of Health 
integrated HIVST in its Test and Treat Guidelines. Based on its experience with HIVST distribution under 
the SOAR study, partner Enda Santé is also leading a large-scale distribution of more than 30,000 HIVST 
kits in Senegal to key populations and their partners, as part of the regional ATLAS project. Led by the 
nongovernmental organization Solthis and funded by UNITAID, this project incorporates self-testing protocols 
from SOAR and is operating in three countries (Côte d’Ivoire, Mali, and Senegal) over a three-year period 
(2018–2021).  
